Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients



Status:Recruiting
Conditions:Renal Impairment / Chronic Kidney Disease, Nephrology
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:18 - Any
Updated:2/13/2019
Start Date:May 22, 2017
End Date:April 2021
Contact:Astellas Pharma Global Development - US
Email:astellas.registration@astellas.com
Phone:800-888-7704

Use our guide to learn which trials are right for you!

A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

The purpose of this study is to assess the efficacy of the bleselumab regimen (basiliximab
induction, tacrolimus, steroids and bleselumab) compared with the Standard of Care (SOC)
regimen (basiliximab induction, tacrolimus, steroids and mycophenolate mofetil [MMF]) in the
prevention of recurrent Focal Segmental Glomerulosclerosis (rFSGS) defined as nephrotic range
proteinuria with protein-creatinine ratio (≥ 3.0 g/g) through 3 months post-transplant.
Death, graft loss or lost to follow-up will be imputed as rFSGS.

The study will consist of the following periods: Screening (Days -21 to -1), Transplant (Day
0), Post-Transplant (Day 0/post-skin closure through 12 months post-transplant). All subjects
will enter into a Screening Period (Days -21 to -1 prior to transplant), undergo a Transplant
(Day 0 [zero]), and are then to be followed for up to 12 months in the Post-Transplant Period
(Day 0 through 12 months post-transplant).

Inclusion Criteria:

- Subject is a recipient of a de novo kidney from a living or deceased donor and has
biopsy-proven, primary FSGS (pFSGS) as a cause of end stage renal disease (ESRD) in
the subject's native kidneys (initial diagnosing biopsy report is required). A subject
who has biopsy-proven pFSGS as a cause of ESRD, and the subject's most current graft
failure(s) is due to the recurrence of FSGS, is eligible.

- Subject is anticipated to receive first oral dose of tacrolimus within 48 hours of
transplant procedure.

- Subject must be willing and able to comply with the study requirements including
prohibited concomitant medication restrictions.

- Subject agrees not to participate in another interventional study while on treatment.

Exclusion Criteria:

- Subject has Induction therapy, other than study-assigned basiliximab, planned as part
of initial immunosuppressive regimen.

- Subject has a diagnosis of secondary FSGS (familial, virus associated, medication,
etc.) or a defined genetic cause of FSGS.

- Subject has previously received any organ transplant including a kidney and the most
current graft failure(s) is not due to the recurrence of FSGS.

- Subject will receive a kidney as part of a multi-organ transplant.

- Subject will receive a dual kidney transplant from a deceased donor.

- Subject will receive a kidney with an anticipated cold ischemia time (CIT) of > 30
hours.

- Subject will receive a kidney that meets BOTH Extended Criteria Donor (ECD) and
Donation after Cardiac Death (DCD) criteria. (A kidney that meets either ECD OR DCD
criteria may be eligible for inclusion.)

- Subject will receive a blood group system (A, AB, B, O, ABO) incompatible (including
A2 into B or O) donor kidney.

- Recipient or donor is known to be seropositive for human immuno-deficiency virus
(HIV).

- Subject has a current calculated panel reactive antibody (cPRA) level > 50%.

- Subject has a current malignancy or a history of malignancy (within the past 5 years),
except nonmetastatic basal or squamous cell carcinoma of the skin that has been
treated successfully, or a renal cell carcinoma that has been treated successfully
more than 2 years prior to transplantation.

- Subject has significant liver disease, defined as having during the past 21 days
consistently elevated aspartate aminotransferase (AST) (SGOT) and/or alanine
aminotransferase (ALT) (SGPT) levels greater than 1.5 times the upper value of the
normal range of the investigational site.

- Subject is known to have a positive test for latent tuberculosis (TB) and has not
previously received adequate anti-microbial therapy/or would require TB prophylaxis
after transplant.

- Subject has an uncontrolled concomitant infection or any other unstable medical
condition that could interfere with the study objectives.

- Subject is concurrently participating in another drug study or has received an
investigational drug up to 30 days or 5 half-lives prior to transplant.

- Subject is currently receiving or has received up to 8 weeks prior to transplant an
immunologic biologic compound (i.e., tumor necrosis factor (TNF) inhibitors, [e.g.,
etanercept, adalimumab], intravenous immunoglobulin (IVIG)). A subject who has
previously received a kidney organ transplant and is currently on an immunosuppression
regimen that includes MMF, or any of its components, must discontinue MMF.

- Subject has previously received bleselumab or participated in a clinical study with
bleselumab.

- Subject has a known hypersensitivity to tacrolimus, MMF, basiliximab, corticosteroids,
or any of the components.

- Subject has any form of substance abuse, psychiatric disorder, or a condition that
could invalidate communication with the Investigator.

- Subject has a clinically significant abnormal electrocardiogram (ECG) at Screening.

- Subject is unlikely to comply with the visits scheduled in the protocol
We found this trial at
37
sites
Edmonton, Alberta
?
mi
from
Edmonton,
Click here to add this to my saved trials
1720 2nd Ave S
Birmingham, Alabama 35233
(205) 934-4011 
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
3550 Jerome Avenue
Bronx, New York 10467
(718) 920-4321
Montefiore Medical Center As the academic medical center and University Hospital for Albert Einstein College...
?
mi
from
Bronx, NY
Click here to add this to my saved trials
5801 South Ellis Avenue
Chicago, Illinois 60637
 773.702.1234
University of Chicago One of the world's premier academic and research institutions, the University of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
3500 Gaston Avenue
Dallas, Texas 75246
1.800.422.9567
Baylor University Medical Center Baylor University Medical Center in Dallas, TX is ranked nationally in...
?
mi
from
Dallas, TX
Click here to add this to my saved trials
425 University Blvd.
Indianapolis, Indiana 46202
(317) 274-4591
Indiana University INDIANA UNIVERSITY is a major multi-campus public research institution, grounded in the liberal...
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Miami, Florida 33124
(305) 284-2211
University of Miami A private research university with more than 15,000 students from around the...
?
mi
from
Miami, FL
Click here to add this to my saved trials
1 Tampa General Cir
Tampa, Florida 33606
(813) 844-7000
Tampa General Hospital In a diverse city known for its rich culture and beautiful beaches,...
?
mi
from
Tampa, FL
Click here to add this to my saved trials
Augusta, Georgia 30912
?
mi
from
Augusta, GA
Click here to add this to my saved trials
Aurora, Colorado 80045
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Baltimore, Maryland 20742
(301) 405-1000
University of Maryland As a globally-connected university offering a world-class education, the University of Maryland...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Buffalo, New York 14215
?
mi
from
Buffalo, NY
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
(919) 962-2211
Univ of North Carolina Carolina’s vibrant people and programs attest to the University’s long-standing place...
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
171 Ashley Avenue
Charleston, South Carolina 29425
843-792-1414
Medical University of South Carolina The Medical University of South Carolina (MUSC) has grown from...
?
mi
from
Charleston, SC
Click here to add this to my saved trials
Charlottesville, Virginia 22903
(434) 924-0311
University of Virginia The University of Virginia is distinctive among institutions of higher education. Founded...
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2035 W Taylor St
Chicago, Illinois
(312) 996-4350
University of Illinois at Chicago A major research university in the heart of one of...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
Fort Worth, Texas 76104
?
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Harrisburg, Pennsylvania 17043
?
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Houston, Texas 77030
?
mi
from
Houston, TX
Click here to add this to my saved trials
94 Old Short Hills Road
Livingston, New Jersey 07039
?
mi
from
Livingston, NJ
Click here to add this to my saved trials
500 S Preston St
Louisville, Kentucky
(502) 852-5555
University of Louisville The University of Louisville is a state supported research university located in...
?
mi
from
Louisville, KY
Click here to add this to my saved trials
2000 Canal Street
New Orleans, Louisiana 70112
?
mi
from
New Orleans, LA
Click here to add this to my saved trials
New York, New York 10016
?
mi
from
New York, NY
Click here to add this to my saved trials
1 Gustave L. Levy Place
New York, New York 10029
?
mi
from
New York, NY
Click here to add this to my saved trials
630 W 168th St
New York, New York
212-305-2862
Columbia University Medical Center Situated on a 20-acre campus in Northern Manhattan and accounting for...
?
mi
from
New York, NY
Click here to add this to my saved trials
3400 Northwest Expressway
Oklahoma City, Oklahoma 73112
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Palo Alto, California
?
mi
from
Palo Alto, CA
Click here to add this to my saved trials
3400 Spruce Street
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
200 Lothrop St
Pittsburgh, Pennsylvania 15213
University of Pittsburgh Medical Center UPMC is one of the leading nonprofit health systems in...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Salt Lake City, Utah 84132
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
1635 Divisadero Street
San Francisco, California 94143
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
45 Castro Street
San Francisco, California 94114
(415) 600-6000
California Pacific Medical Center California Pacific Medical Center is one of the largest private, not-for-profit,...
?
mi
from
San Francisco, CA
Click here to add this to my saved trials
5300 Tallman Ave NW
Seattle, Washington 98122
(206) 782-2700
Swedish Medical Center Since 1910, Swedish has been the region's hallmark for excellence in health...
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Tucson, Arizona 85721
(520) 621-2211
University of Arizona The University of Arizona is a premier, public research university. Established in...
?
mi
from
Tucson, AZ
Click here to add this to my saved trials